Cooperative Agreement U01GH002249

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $837,589 Cooperative Agreement to the Ministere De La Sante Et De L'Action Social in Senegal under the CDC Investigations and Technical Assistance program (CFDA 93.283). The funding supports a range of public health initiatives focused on controlling communicable diseases, chronic diseases, and other preventable health conditions through research, surveillance, epidemiological investigations, and technical assistance. The 5-year...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $147,290 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the University of Sciences, Techniques and Technologies of Bamako (Usttb) in Mali. The grant, titled "Understanding the Persistence of Dengue Epidemic and Associated Risk Factors in Urban Bamako Mali", aims to assess the burden and risk factors associated with dengue fever disease (DFD) in Mali. The key objectives...

This $450,000 Project Grant from the U.S. Agency for International Development Senegal will fund the development and support of a community-led HIV monitoring platform in Senegal. Awa Help For Women At Risk Of Aids will collaborate closely with independent civil society organizations and host country governments to improve access to and quality of HIV services at PEPFAR-focused sites through February 2023. The grant is awarded under the USAID Foreign Assistance for Programs Overseas program...

The Centers for Disease Control and Prevention (CDC) awarded a $650,000 cooperative agreement to the Pasteur Institute of Ivory Coast (Institut Pasteur De Cote D'Ivoire) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The five-year award, effective from September 30, 2025 to September 29, 2030, aims to strengthen public health laboratory systems for priority disease detection and outbreak surveillance in Côte d'Ivoire. The Pasteur Institute, a non-profit organization...

The National Institute of Allergy and Infectious Diseases (NIAID), through the Allergy and Infectious Diseases Research (CFDA 93.855) program, has awarded a $112,943 project grant to the Jos University Teaching Hospital (JUTH) in Nigeria. The grant, effective August 2024 through January 2026, aims to build research administration capabilities and develop electronic grant management systems at JUTH and its partner institutions in West Africa. Specifically, the project will train new and junior...

This Cooperative Agreement was awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to build research infrastructure for studying Alzheimer's disease and related dementias (AD/ADRD) in Côte d'Ivoire. The total funding amount is $517,593, with an award date of April 15, 2025 and an ultimate completion date of March 31, 2027. The project is a collaboration between Johns Hopkins Bloomberg School of Public Health (JHBSPH) in the U.S. and Ecole Nationale de Statistiques et...

The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $201,528 Project Grant to the Regents of the University of Minnesota to develop a cost-effective diagnostic algorithm using point-of-care tests to guide antimicrobial management for patients with solid tumors receiving chemotherapy in Uganda. The project aims to understand the association between HIV status and the microbiology of...

This $664,331 Cooperative Agreement awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports a research project titled "Steroids and Enhanced Antibiotics for the Treatment of Patients in Africa with Refractory Sepsis: STARS Trial". The project aims to investigate the use of immediate hydrocortisone and enhanced antibiotic treatments to improve 28-day mortality for sepsis patients in sub-Saharan Africa,...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) will support research to define the immune response to Plasmodium vaccination and test an adjuvant to boost immunity against malaria. The $205,125 award to the Hennepin Healthcare Research Institute will utilize an improved small animal model to compare vaccine responses in specific pathogen-free (SPF) mice versus...

This Cooperative Agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283), provides $265,000.00 in funding to the Direction Of Disease Control, Epidemics And Pandemics in Cameroon. The purpose of this 5-year award, with a start date of September 30, 2025 and a completion date of September 29, 2030, is to protect and improve public health globally by building and strengthening public health impact system...